nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—CYP2D6—Hydroxyurea—head and neck cancer	0.232	0.295	CbGbCtD
Ranitidine—CYP3A5—Docetaxel—head and neck cancer	0.11	0.14	CbGbCtD
Ranitidine—CYP1A2—Fluorouracil—head and neck cancer	0.107	0.137	CbGbCtD
Ranitidine—ABCB1—Vinblastine—head and neck cancer	0.0871	0.111	CbGbCtD
Ranitidine—CYP2D6—Vinblastine—head and neck cancer	0.082	0.104	CbGbCtD
Ranitidine—ABCB1—Docetaxel—head and neck cancer	0.0718	0.0914	CbGbCtD
Ranitidine—CYP3A4—Vinblastine—head and neck cancer	0.0522	0.0664	CbGbCtD
Ranitidine—CYP3A4—Docetaxel—head and neck cancer	0.043	0.0547	CbGbCtD
Ranitidine—Emotional distress—Hydroxyurea—head and neck cancer	0.0102	0.0476	CcSEcCtD
Ranitidine—Emotional distress—Fluorouracil—head and neck cancer	0.00733	0.0343	CcSEcCtD
Ranitidine—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00641	0.03	CcSEcCtD
Ranitidine—Foetor hepaticus—Docetaxel—head and neck cancer	0.00396	0.0185	CcSEcCtD
Ranitidine—Hepatic failure—Hydroxyurea—head and neck cancer	0.0035	0.0164	CcSEcCtD
Ranitidine—Liver disorder—Docetaxel—head and neck cancer	0.0033	0.0154	CcSEcCtD
Ranitidine—Dermatitis contact—Fluorouracil—head and neck cancer	0.00308	0.0144	CcSEcCtD
Ranitidine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00294	0.0138	CcSEcCtD
Ranitidine—Angina pectoris—Vinblastine—head and neck cancer	0.0029	0.0136	CcSEcCtD
Ranitidine—Breast disorder—Hydroxyurea—head and neck cancer	0.00284	0.0133	CcSEcCtD
Ranitidine—Pancytopenia—Vinblastine—head and neck cancer	0.00283	0.0132	CcSEcCtD
Ranitidine—Pancreatitis—Hydroxyurea—head and neck cancer	0.00266	0.0125	CcSEcCtD
Ranitidine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00258	0.0121	CcSEcCtD
Ranitidine—Photosensitivity—Fluorouracil—head and neck cancer	0.00258	0.012	CcSEcCtD
Ranitidine—Neutropenia—Hydroxyurea—head and neck cancer	0.00254	0.0119	CcSEcCtD
Ranitidine—Agranulocytosis—Vinblastine—head and neck cancer	0.00248	0.0116	CcSEcCtD
Ranitidine—Hepatocellular injury—Docetaxel—head and neck cancer	0.00225	0.0105	CcSEcCtD
Ranitidine—Hallucination—Hydroxyurea—head and neck cancer	0.00216	0.0101	CcSEcCtD
Ranitidine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00215	0.0101	CcSEcCtD
Ranitidine—Alopecia—Vinblastine—head and neck cancer	0.00211	0.00985	CcSEcCtD
Ranitidine—Lightheadedness—Docetaxel—head and neck cancer	0.00201	0.00941	CcSEcCtD
Ranitidine—Dysphagia—Fluorouracil—head and neck cancer	0.00196	0.00914	CcSEcCtD
Ranitidine—Eosinophilia—Fluorouracil—head and neck cancer	0.00194	0.00905	CcSEcCtD
Ranitidine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00193	0.009	CcSEcCtD
Ranitidine—Alopecia—Hydroxyurea—head and neck cancer	0.00192	0.00898	CcSEcCtD
Ranitidine—Anaemia—Vinblastine—head and neck cancer	0.00192	0.00897	CcSEcCtD
Ranitidine—Angina pectoris—Fluorouracil—head and neck cancer	0.0019	0.00891	CcSEcCtD
Ranitidine—Erythema—Hydroxyurea—head and neck cancer	0.00189	0.00885	CcSEcCtD
Ranitidine—Malaise—Vinblastine—head and neck cancer	0.00187	0.00875	CcSEcCtD
Ranitidine—Vertigo—Vinblastine—head and neck cancer	0.00186	0.00872	CcSEcCtD
Ranitidine—Leukopenia—Vinblastine—head and neck cancer	0.00186	0.00869	CcSEcCtD
Ranitidine—Pancytopenia—Fluorouracil—head and neck cancer	0.00186	0.00868	CcSEcCtD
Ranitidine—Hepatic failure—Docetaxel—head and neck cancer	0.00182	0.0085	CcSEcCtD
Ranitidine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00178	0.00834	CcSEcCtD
Ranitidine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00176	0.00821	CcSEcCtD
Ranitidine—Pneumonia—Fluorouracil—head and neck cancer	0.00175	0.0082	CcSEcCtD
Ranitidine—Anaemia—Hydroxyurea—head and neck cancer	0.00175	0.00818	CcSEcCtD
Ranitidine—Discomfort—Vinblastine—head and neck cancer	0.00175	0.00816	CcSEcCtD
Ranitidine—Malaise—Hydroxyurea—head and neck cancer	0.00171	0.00798	CcSEcCtD
Ranitidine—Leukopenia—Hydroxyurea—head and neck cancer	0.00169	0.00792	CcSEcCtD
Ranitidine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00166	0.00775	CcSEcCtD
Ranitidine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00163	0.00761	CcSEcCtD
Ranitidine—Discomfort—Hydroxyurea—head and neck cancer	0.00159	0.00744	CcSEcCtD
Ranitidine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00151	0.00707	CcSEcCtD
Ranitidine—Abdominal pain upper—Docetaxel—head and neck cancer	0.00149	0.00697	CcSEcCtD
Ranitidine—Breast disorder—Docetaxel—head and neck cancer	0.00148	0.0069	CcSEcCtD
Ranitidine—Pain—Vinblastine—head and neck cancer	0.00145	0.00677	CcSEcCtD
Ranitidine—Constipation—Vinblastine—head and neck cancer	0.00145	0.00677	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00144	0.00673	CcSEcCtD
Ranitidine—Dysphagia—Docetaxel—head and neck cancer	0.00141	0.0066	CcSEcCtD
Ranitidine—Arrhythmia—Fluorouracil—head and neck cancer	0.0014	0.00654	CcSEcCtD
Ranitidine—Feeling abnormal—Vinblastine—head and neck cancer	0.0014	0.00653	CcSEcCtD
Ranitidine—Bronchospasm—Docetaxel—head and neck cancer	0.00139	0.00649	CcSEcCtD
Ranitidine—Alopecia—Fluorouracil—head and neck cancer	0.00138	0.00647	CcSEcCtD
Ranitidine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00138	0.00644	CcSEcCtD
Ranitidine—Angina pectoris—Docetaxel—head and neck cancer	0.00137	0.00643	CcSEcCtD
Ranitidine—Somnolence—Hydroxyurea—head and neck cancer	0.00137	0.00642	CcSEcCtD
Ranitidine—Erythema—Fluorouracil—head and neck cancer	0.00136	0.00637	CcSEcCtD
Ranitidine—Pancytopenia—Docetaxel—head and neck cancer	0.00134	0.00627	CcSEcCtD
Ranitidine—Abdominal pain—Vinblastine—head and neck cancer	0.00134	0.00626	CcSEcCtD
Ranitidine—Constipation—Hydroxyurea—head and neck cancer	0.00132	0.00618	CcSEcCtD
Ranitidine—Pain—Hydroxyurea—head and neck cancer	0.00132	0.00618	CcSEcCtD
Ranitidine—Neutropenia—Docetaxel—head and neck cancer	0.00132	0.00617	CcSEcCtD
Ranitidine—Vision blurred—Fluorouracil—head and neck cancer	0.00128	0.006	CcSEcCtD
Ranitidine—Weight decreased—Docetaxel—head and neck cancer	0.00128	0.00597	CcSEcCtD
Ranitidine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00127	0.00595	CcSEcCtD
Ranitidine—Pneumonia—Docetaxel—head and neck cancer	0.00127	0.00592	CcSEcCtD
Ranitidine—Anaemia—Fluorouracil—head and neck cancer	0.00126	0.00589	CcSEcCtD
Ranitidine—Hypersensitivity—Vinblastine—head and neck cancer	0.00125	0.00583	CcSEcCtD
Ranitidine—Jaundice—Docetaxel—head and neck cancer	0.00123	0.00573	CcSEcCtD
Ranitidine—Body temperature increased—Hydroxyurea—head and neck cancer	0.00122	0.00571	CcSEcCtD
Ranitidine—Leukopenia—Fluorouracil—head and neck cancer	0.00122	0.0057	CcSEcCtD
Ranitidine—Agranulocytosis—Docetaxel—head and neck cancer	0.00117	0.00549	CcSEcCtD
Ranitidine—Chest pain—Fluorouracil—head and neck cancer	0.00116	0.00542	CcSEcCtD
Ranitidine—Myalgia—Fluorouracil—head and neck cancer	0.00116	0.00542	CcSEcCtD
Ranitidine—Diarrhoea—Vinblastine—head and neck cancer	0.00116	0.00542	CcSEcCtD
Ranitidine—Discomfort—Fluorouracil—head and neck cancer	0.00115	0.00536	CcSEcCtD
Ranitidine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00114	0.00532	CcSEcCtD
Ranitidine—Hepatitis—Docetaxel—head and neck cancer	0.00113	0.00528	CcSEcCtD
Ranitidine—Confusional state—Fluorouracil—head and neck cancer	0.00112	0.00524	CcSEcCtD
Ranitidine—Dizziness—Vinblastine—head and neck cancer	0.00112	0.00524	CcSEcCtD
Ranitidine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00111	0.0052	CcSEcCtD
Ranitidine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00109	0.00509	CcSEcCtD
Ranitidine—Tachycardia—Fluorouracil—head and neck cancer	0.00109	0.00507	CcSEcCtD
Ranitidine—Vomiting—Vinblastine—head and neck cancer	0.00108	0.00504	CcSEcCtD
Ranitidine—Erythema multiforme—Docetaxel—head and neck cancer	0.00107	0.00499	CcSEcCtD
Ranitidine—Headache—Vinblastine—head and neck cancer	0.00106	0.00496	CcSEcCtD
Ranitidine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00106	0.00494	CcSEcCtD
Ranitidine—Hypotension—Fluorouracil—head and neck cancer	0.00104	0.00486	CcSEcCtD
Ranitidine—Dizziness—Hydroxyurea—head and neck cancer	0.00102	0.00478	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00101	0.00474	CcSEcCtD
Ranitidine—Arrhythmia—Docetaxel—head and neck cancer	0.00101	0.00472	CcSEcCtD
Ranitidine—Nausea—Vinblastine—head and neck cancer	0.00101	0.0047	CcSEcCtD
Ranitidine—Insomnia—Fluorouracil—head and neck cancer	0.00101	0.0047	CcSEcCtD
Ranitidine—Alopecia—Docetaxel—head and neck cancer	0.000998	0.00467	CcSEcCtD
Ranitidine—Dyspnoea—Fluorouracil—head and neck cancer	0.000991	0.00463	CcSEcCtD
Ranitidine—Somnolence—Fluorouracil—head and neck cancer	0.000989	0.00462	CcSEcCtD
Ranitidine—Erythema—Docetaxel—head and neck cancer	0.000983	0.0046	CcSEcCtD
Ranitidine—Vomiting—Hydroxyurea—head and neck cancer	0.000982	0.00459	CcSEcCtD
Ranitidine—Rash—Hydroxyurea—head and neck cancer	0.000974	0.00455	CcSEcCtD
Ranitidine—Dermatitis—Hydroxyurea—head and neck cancer	0.000973	0.00455	CcSEcCtD
Ranitidine—Headache—Hydroxyurea—head and neck cancer	0.000968	0.00452	CcSEcCtD
Ranitidine—Pain—Fluorouracil—head and neck cancer	0.000951	0.00445	CcSEcCtD
Ranitidine—Nausea—Hydroxyurea—head and neck cancer	0.000918	0.00429	CcSEcCtD
Ranitidine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000916	0.00428	CcSEcCtD
Ranitidine—Anaemia—Docetaxel—head and neck cancer	0.000909	0.00425	CcSEcCtD
Ranitidine—Urticaria—Fluorouracil—head and neck cancer	0.000883	0.00413	CcSEcCtD
Ranitidine—Leukopenia—Docetaxel—head and neck cancer	0.00088	0.00412	CcSEcCtD
Ranitidine—Body temperature increased—Fluorouracil—head and neck cancer	0.000879	0.00411	CcSEcCtD
Ranitidine—Arthralgia—Docetaxel—head and neck cancer	0.000837	0.00391	CcSEcCtD
Ranitidine—Chest pain—Docetaxel—head and neck cancer	0.000837	0.00391	CcSEcCtD
Ranitidine—Myalgia—Docetaxel—head and neck cancer	0.000837	0.00391	CcSEcCtD
Ranitidine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000819	0.00383	CcSEcCtD
Ranitidine—Confusional state—Docetaxel—head and neck cancer	0.000809	0.00378	CcSEcCtD
Ranitidine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000803	0.00375	CcSEcCtD
Ranitidine—Pruritus—Fluorouracil—head and neck cancer	0.000787	0.00368	CcSEcCtD
Ranitidine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000786	0.00367	CcSEcCtD
Ranitidine—Tachycardia—Docetaxel—head and neck cancer	0.000783	0.00366	CcSEcCtD
Ranitidine—Diarrhoea—Fluorouracil—head and neck cancer	0.000761	0.00356	CcSEcCtD
Ranitidine—Hypotension—Docetaxel—head and neck cancer	0.00075	0.00351	CcSEcCtD
Ranitidine—Dizziness—Fluorouracil—head and neck cancer	0.000735	0.00344	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000731	0.00342	CcSEcCtD
Ranitidine—Insomnia—Docetaxel—head and neck cancer	0.000726	0.00339	CcSEcCtD
Ranitidine—Dyspnoea—Docetaxel—head and neck cancer	0.000716	0.00335	CcSEcCtD
Ranitidine—Somnolence—Docetaxel—head and neck cancer	0.000714	0.00334	CcSEcCtD
Ranitidine—Vomiting—Fluorouracil—head and neck cancer	0.000707	0.00331	CcSEcCtD
Ranitidine—Rash—Fluorouracil—head and neck cancer	0.000701	0.00328	CcSEcCtD
Ranitidine—Dermatitis—Fluorouracil—head and neck cancer	0.0007	0.00327	CcSEcCtD
Ranitidine—Headache—Fluorouracil—head and neck cancer	0.000697	0.00326	CcSEcCtD
Ranitidine—Pain—Docetaxel—head and neck cancer	0.000686	0.00321	CcSEcCtD
Ranitidine—Constipation—Docetaxel—head and neck cancer	0.000686	0.00321	CcSEcCtD
Ranitidine—Feeling abnormal—Docetaxel—head and neck cancer	0.000661	0.00309	CcSEcCtD
Ranitidine—Nausea—Fluorouracil—head and neck cancer	0.000661	0.00309	CcSEcCtD
Ranitidine—Abdominal pain—Docetaxel—head and neck cancer	0.000634	0.00297	CcSEcCtD
Ranitidine—Body temperature increased—Docetaxel—head and neck cancer	0.000634	0.00297	CcSEcCtD
Ranitidine—Hypersensitivity—Docetaxel—head and neck cancer	0.000591	0.00276	CcSEcCtD
Ranitidine—Pruritus—Docetaxel—head and neck cancer	0.000568	0.00265	CcSEcCtD
Ranitidine—Diarrhoea—Docetaxel—head and neck cancer	0.000549	0.00257	CcSEcCtD
Ranitidine—Dizziness—Docetaxel—head and neck cancer	0.000531	0.00248	CcSEcCtD
Ranitidine—Vomiting—Docetaxel—head and neck cancer	0.00051	0.00239	CcSEcCtD
Ranitidine—Rash—Docetaxel—head and neck cancer	0.000506	0.00237	CcSEcCtD
Ranitidine—Dermatitis—Docetaxel—head and neck cancer	0.000506	0.00236	CcSEcCtD
Ranitidine—Headache—Docetaxel—head and neck cancer	0.000503	0.00235	CcSEcCtD
Ranitidine—Nausea—Docetaxel—head and neck cancer	0.000477	0.00223	CcSEcCtD
Ranitidine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	1.17e-05	0.0212	CbGpPWpGaD
Ranitidine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	1.16e-05	0.0212	CbGpPWpGaD
Ranitidine—CYP3A5—Xenobiotics—CYP1A1—head and neck cancer	1.02e-05	0.0186	CbGpPWpGaD
Ranitidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	9.85e-06	0.018	CbGpPWpGaD
Ranitidine—CYP3A5—Tamoxifen metabolism—CYP1A1—head and neck cancer	9.83e-06	0.0179	CbGpPWpGaD
Ranitidine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	9e-06	0.0164	CbGpPWpGaD
Ranitidine—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	8.69e-06	0.0158	CbGpPWpGaD
Ranitidine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	8.69e-06	0.0158	CbGpPWpGaD
Ranitidine—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	7.9e-06	0.0144	CbGpPWpGaD
Ranitidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	7.86e-06	0.0143	CbGpPWpGaD
Ranitidine—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	7.6e-06	0.0138	CbGpPWpGaD
Ranitidine—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	7.36e-06	0.0134	CbGpPWpGaD
Ranitidine—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	7.27e-06	0.0132	CbGpPWpGaD
Ranitidine—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	7.06e-06	0.0129	CbGpPWpGaD
Ranitidine—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	6.99e-06	0.0127	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	6.95e-06	0.0127	CbGpPWpGaD
Ranitidine—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	6.7e-06	0.0122	CbGpPWpGaD
Ranitidine—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	6.15e-06	0.0112	CbGpPWpGaD
Ranitidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	6.07e-06	0.0111	CbGpPWpGaD
Ranitidine—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	5.92e-06	0.0108	CbGpPWpGaD
Ranitidine—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	5.87e-06	0.0107	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	5.72e-06	0.0104	CbGpPWpGaD
Ranitidine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	5.68e-06	0.0103	CbGpPWpGaD
Ranitidine—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	5.45e-06	0.00994	CbGpPWpGaD
Ranitidine—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	5.4e-06	0.00984	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—KISS1—head and neck cancer	5.29e-06	0.00965	CbGpPWpGaD
Ranitidine—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	5.17e-06	0.00942	CbGpPWpGaD
Ranitidine—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	4.75e-06	0.00866	CbGpPWpGaD
Ranitidine—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	4.57e-06	0.00833	CbGpPWpGaD
Ranitidine—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	4.57e-06	0.00833	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—GRP—head and neck cancer	4.36e-06	0.00795	CbGpPWpGaD
Ranitidine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.24e-06	0.00773	CbGpPWpGaD
Ranitidine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.19e-06	0.00763	CbGpPWpGaD
Ranitidine—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	4.03e-06	0.00734	CbGpPWpGaD
Ranitidine—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	4.02e-06	0.00732	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—NAT2—head and neck cancer	3.9e-06	0.00711	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	3.85e-06	0.00701	CbGpPWpGaD
Ranitidine—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	3.83e-06	0.00699	CbGpPWpGaD
Ranitidine—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	3.8e-06	0.00692	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—ATP7B—head and neck cancer	3.58e-06	0.00652	CbGpPWpGaD
Ranitidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.44e-06	0.00627	CbGpPWpGaD
Ranitidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	3.28e-06	0.00598	CbGpPWpGaD
Ranitidine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	3.24e-06	0.0059	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	3.16e-06	0.00576	CbGpPWpGaD
Ranitidine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	3.16e-06	0.00576	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	3.16e-06	0.00576	CbGpPWpGaD
Ranitidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	3.02e-06	0.0055	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—NAT2—head and neck cancer	3.02e-06	0.0055	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—KISS1—head and neck cancer	2.99e-06	0.00545	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	2.99e-06	0.00544	CbGpPWpGaD
Ranitidine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	2.98e-06	0.00543	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	2.98e-06	0.00542	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	2.96e-06	0.00539	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	2.77e-06	0.00506	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	2.74e-06	0.00499	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—KISS1—head and neck cancer	2.72e-06	0.00495	CbGpPWpGaD
Ranitidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.66e-06	0.00485	CbGpPWpGaD
Ranitidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	2.56e-06	0.00466	CbGpPWpGaD
Ranitidine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	2.52e-06	0.0046	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	2.48e-06	0.00451	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—GRP—head and neck cancer	2.46e-06	0.00449	CbGpPWpGaD
Ranitidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.45e-06	0.00446	CbGpPWpGaD
Ranitidine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	2.44e-06	0.00445	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	2.35e-06	0.00428	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	2.32e-06	0.00423	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	2.32e-06	0.00423	CbGpPWpGaD
Ranitidine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	2.26e-06	0.00411	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	2.25e-06	0.00411	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—GRP—head and neck cancer	2.24e-06	0.00408	CbGpPWpGaD
Ranitidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.07e-06	0.00378	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—UROD—head and neck cancer	2.07e-06	0.00377	CbGpPWpGaD
Ranitidine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	1.98e-06	0.00362	CbGpPWpGaD
Ranitidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	1.97e-06	0.00359	CbGpPWpGaD
Ranitidine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	1.95e-06	0.00355	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	1.93e-06	0.00351	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	1.9e-06	0.00346	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	1.88e-06	0.00343	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	1.87e-06	0.00342	CbGpPWpGaD
Ranitidine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	1.83e-06	0.00333	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	1.81e-06	0.00331	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	1.8e-06	0.00328	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	1.79e-06	0.00326	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	1.76e-06	0.00321	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	1.74e-06	0.00318	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—UROD—head and neck cancer	1.61e-06	0.00293	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KISS1—head and neck cancer	1.6e-06	0.00293	CbGpPWpGaD
Ranitidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	1.6e-06	0.00291	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	1.49e-06	0.00272	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	1.48e-06	0.0027	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	1.47e-06	0.00268	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL2—head and neck cancer	1.42e-06	0.00258	CbGpPWpGaD
Ranitidine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	1.41e-06	0.00257	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	1.39e-06	0.00254	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	1.39e-06	0.00253	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	1.37e-06	0.0025	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.36e-06	0.00248	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	1.35e-06	0.00247	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	1.35e-06	0.00246	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	1.33e-06	0.00243	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	1.33e-06	0.00243	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	1.33e-06	0.00243	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GRP—head and neck cancer	1.32e-06	0.00241	CbGpPWpGaD
Ranitidine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	1.3e-06	0.00237	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT6—head and neck cancer	1.28e-06	0.00234	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	1.28e-06	0.00234	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—UROD—head and neck cancer	1.24e-06	0.00226	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—UROD—head and neck cancer	1.21e-06	0.00221	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	1.2e-06	0.00219	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	1.16e-06	0.00212	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	1.15e-06	0.00209	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—UROD—head and neck cancer	1.14e-06	0.00208	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—YAP1—head and neck cancer	1.14e-06	0.00207	CbGpPWpGaD
Ranitidine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	1.1e-06	0.00201	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	1.09e-06	0.00198	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	1.07e-06	0.00195	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—UROD—head and neck cancer	9.68e-07	0.00176	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.64e-07	0.00176	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	9.25e-07	0.00169	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	8.96e-07	0.00163	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	8.87e-07	0.00162	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	8.84e-07	0.00161	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—MAPK1—head and neck cancer	8.79e-07	0.0016	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NAT2—head and neck cancer	8.59e-07	0.00157	CbGpPWpGaD
Ranitidine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	8.49e-07	0.00155	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	8.38e-07	0.00153	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.94e-07	0.00145	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	7.54e-07	0.00137	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—DPYD—head and neck cancer	7.53e-07	0.00137	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.51e-07	0.00137	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—UROD—head and neck cancer	7.47e-07	0.00136	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—YAP1—head and neck cancer	7.15e-07	0.0013	CbGpPWpGaD
Ranitidine—SLC22A1—Transmission across Chemical Synapses—HRAS—head and neck cancer	7.06e-07	0.00129	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.81e-07	0.00124	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—MAPK1—head and neck cancer	6.74e-07	0.00123	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NAT2—head and neck cancer	6.67e-07	0.00122	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	6.58e-07	0.0012	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—IL2—head and neck cancer	6.56e-07	0.0012	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL2—head and neck cancer	5.96e-07	0.00109	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.94e-07	0.00108	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—DPYD—head and neck cancer	5.85e-07	0.00107	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.62e-07	0.00102	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—YAP1—head and neck cancer	5.55e-07	0.00101	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.48e-07	0.000999	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.42e-07	0.000989	CbGpPWpGaD
Ranitidine—SLC22A1—Neuronal System—HRAS—head and neck cancer	5.41e-07	0.000985	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5.35e-07	0.000974	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5.34e-07	0.000974	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NAT2—head and neck cancer	5.16e-07	0.00094	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—NOTCH1—head and neck cancer	5.12e-07	0.000933	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NAT2—head and neck cancer	5.04e-07	0.000918	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—MAPK3—head and neck cancer	4.79e-07	0.000874	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NAT2—head and neck cancer	4.75e-07	0.000865	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.64e-07	0.000845	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—MAPK1—head and neck cancer	4.56e-07	0.000831	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—EGFR—head and neck cancer	4.56e-07	0.000831	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—DPYD—head and neck cancer	4.52e-07	0.000825	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.49e-07	0.000818	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—DPYD—head and neck cancer	4.42e-07	0.000805	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PIK3CA—head and neck cancer	4.36e-07	0.000794	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—YAP1—head and neck cancer	4.29e-07	0.000782	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—TYMS—head and neck cancer	4.29e-07	0.000782	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.27e-07	0.000778	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GSTM1—head and neck cancer	4.24e-07	0.000773	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.23e-07	0.00077	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—YAP1—head and neck cancer	4.19e-07	0.000764	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—DPYD—head and neck cancer	4.16e-07	0.000758	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GPX1—head and neck cancer	4.06e-07	0.000741	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CYP1A1—head and neck cancer	4.02e-07	0.000733	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NAT2—head and neck cancer	4.02e-07	0.000733	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PIK3CA—head and neck cancer	3.96e-07	0.000721	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—YAP1—head and neck cancer	3.95e-07	0.00072	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.79e-07	0.000691	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—HRAS—head and neck cancer	3.66e-07	0.000667	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—AKT1—head and neck cancer	3.56e-07	0.000649	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—DPYD—head and neck cancer	3.52e-07	0.000642	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2—head and neck cancer	3.52e-07	0.000642	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCND1—head and neck cancer	3.43e-07	0.000626	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—YAP1—head and neck cancer	3.34e-07	0.00061	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—TYMS—head and neck cancer	3.33e-07	0.000608	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTEN—head and neck cancer	3.31e-07	0.000604	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTM1—head and neck cancer	3.3e-07	0.000601	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT1—head and neck cancer	3.23e-07	0.000589	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.23e-07	0.000588	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GPX1—head and neck cancer	3.16e-07	0.000575	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	3.12e-07	0.000569	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NAT2—head and neck cancer	3.1e-07	0.000565	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—head and neck cancer	2.99e-07	0.000545	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—head and neck cancer	2.96e-07	0.00054	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK3—head and neck cancer	2.83e-07	0.000516	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.81e-07	0.000513	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—DPYD—head and neck cancer	2.72e-07	0.000496	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MAPK1—head and neck cancer	2.69e-07	0.000491	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—head and neck cancer	2.69e-07	0.000491	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—YAP1—head and neck cancer	2.58e-07	0.000471	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TYMS—head and neck cancer	2.58e-07	0.00047	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.55e-07	0.000464	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TYMS—head and neck cancer	2.52e-07	0.000459	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.51e-07	0.000458	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTM1—head and neck cancer	2.49e-07	0.000453	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GPX1—head and neck cancer	2.44e-07	0.000445	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.42e-07	0.00044	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—head and neck cancer	2.39e-07	0.000436	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPX1—head and neck cancer	2.38e-07	0.000434	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TYMS—head and neck cancer	2.37e-07	0.000432	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1A1—head and neck cancer	2.36e-07	0.00043	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.34e-07	0.000427	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CA—head and neck cancer	2.34e-07	0.000426	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—head and neck cancer	2.26e-07	0.000412	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPX1—head and neck cancer	2.24e-07	0.000409	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.22e-07	0.000405	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.19e-07	0.000399	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—HRAS—head and neck cancer	2.16e-07	0.000394	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—head and neck cancer	2.09e-07	0.00038	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TYMS—head and neck cancer	2.01e-07	0.000366	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.99e-07	0.000362	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.98e-07	0.000362	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT1—head and neck cancer	1.91e-07	0.000348	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPX1—head and neck cancer	1.9e-07	0.000347	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.88e-07	0.000343	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.86e-07	0.000339	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—head and neck cancer	1.62e-07	0.000295	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TYMS—head and neck cancer	1.55e-07	0.000283	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.55e-07	0.000282	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.53e-07	0.000279	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CA—head and neck cancer	1.47e-07	0.000268	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPX1—head and neck cancer	1.47e-07	0.000267	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.45e-07	0.000265	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.44e-07	0.000262	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—head and neck cancer	1.4e-07	0.000256	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.32e-07	0.000241	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—head and neck cancer	1.25e-07	0.000228	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—head and neck cancer	1.22e-07	0.000223	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AKT1—head and neck cancer	1.2e-07	0.000219	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.15e-07	0.00021	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.14e-07	0.000208	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—head and neck cancer	1.12e-07	0.000204	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—head and neck cancer	9.76e-08	0.000178	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AKT1—head and neck cancer	9.34e-08	0.00017	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	8.84e-08	0.000161	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.64e-08	0.000157	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CA—head and neck cancer	8.63e-08	0.000157	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	8.13e-08	0.000148	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—head and neck cancer	7.53e-08	0.000137	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AKT1—head and neck cancer	7.22e-08	0.000132	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AKT1—head and neck cancer	7.05e-08	0.000128	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	6.89e-08	0.000126	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AKT1—head and neck cancer	6.64e-08	0.000121	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKT1—head and neck cancer	5.63e-08	0.000103	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.31e-08	9.69e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKT1—head and neck cancer	4.34e-08	7.91e-05	CbGpPWpGaD
